Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

4.615 +0.235 (+5.37%)

Delayed Quote Updated: 2:33 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2 3 4 5 6 7 8 9

...

27 28 Next >

Clover Health (NASDAQ:CLOV) Reports Sales Below Analyst Estimates In Q4 Earnings

February 27, 2025

Health insurance company Clover Health (NASDAQ:CLOV) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share was...

Via StockStory

Trump's Tariffs, Potential 'Stagflation': What's Driving Markets Thursday? ↗

February 27, 2025

The S&P 500 and Nasdaq both slipped into the red, reversing early gains on Thursday, while the Dow Jones remained in positive territory in midday trading.

Via Benzinga

Topics Government Stocks

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

What To Expect From Clover Health’s (CLOV) Q4 Earnings

February 26, 2025

Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow afternoon. Here’s what to look for.

Via StockStory

(CLOV) - Analyzing Clover Health Investments's Short Interest ↗

December 10, 2024

Via Benzinga

How Is The Market Feeling About Clover Health Investments? ↗

October 25, 2024

Via Benzinga

Looking Into Clover Health Investments's Recent Short Interest ↗

October 03, 2024

Via Benzinga

Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc. ↗

January 22, 2025

Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in.

Via Benzinga

Topics Stocks

Ten Young Ones ↗

November 30, 2024

Here are a variety of lesser-known charts from my “Recents” watch list. Quite a few of them look like good bullish plays.

Via Talk Markets

Topics Stocks / Equities

Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential

November 20, 2024

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:TDOC),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:CLOV) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence Fraud

How Is The Market Feeling About Clover Health Investments? ↗

September 09, 2024

Via Benzinga

Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential

November 20, 2024

From FN Media Group LLC

Via GlobeNewswire

Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare ↗

November 09, 2024

Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.

Via Benzinga

Topics Government

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 07, 2024

Via Benzinga

AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories ↗

October 17, 2024

AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says.

Via Benzinga

Why Clover Health (CLOV) Stock Is Rising ↗

October 11, 2024

Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025.

Via Benzinga

Nvidia, Palantir, Clover Health, Joby Aviation, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

October 02, 2024

U.S. indices closed Wednesday in positive territory, with the Dow Jones Industrial Average increasing by 0.09% to 42,196.52.

Via Benzinga

Topics Stocks

Clover Health Stock Surges Over 29% On High Volume: Recap ↗

October 02, 2024

Clover Health Investments shares are trading higher Wednesday amid increased trading volume and gaining traction across social media platforms. Here's what you need to know.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 02, 2024

Via Benzinga

RPM International Posts Upbeat Earnings, Joins Joby Aviation, Ciena And Other Big Stocks Moving Higher On Wednesday ↗

October 02, 2024

Via Benzinga

Hindenburg Research Issued a Scathing Short Report on Super Micro Computer. This Is What Happened to 3 Other Big Stocks It Targeted. ↗

September 10, 2024

Short reports can be crippling for a stock in the short term, but what about the longer run?

Via The Motley Fool

What's Going On With Clover Health Shares Wednesday? ↗

September 04, 2024

Clover Health stock is moving higher Wednesday after the company's subsidiary, Counterpart Health, announced a multi-year agreement with Iowa Clinic.

Via Benzinga

Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

September 04, 2024

Via Benzinga

Clover Health Stock Is Climbing After The Close: What's Going On? ↗

September 03, 2024

Clover Health Investments Corp shares are trading higher in extended trading Tuesday after one of the company's subsidiaries announced a multi-year agreement with The Iowa Clinic.

Via Benzinga

PVH, nCino, Marathon Digital And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 28, 2024

Via Benzinga

Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

August 22, 2024

Via Benzinga

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 19, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

August 19, 2024

Via Benzinga

CLOV Stock Alert: What to Know About Clover Health’s Big Insider Buy ↗

August 14, 2024

CLOV stock sold for under $1 per share recently. Clover could be on the verge of a sale, or this could be a short squeeze.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.